Rockwell Medical (RMTI) Gains from Investment Securities (2016 - 2025)
Rockwell Medical's Gains from Investment Securities history spans 15 years, with the latest figure at -$444000.0 for Q4 2025.
- For Q4 2025, Gains from Investment Securities fell 412.68% year-over-year to -$444000.0; the TTM value through Dec 2025 reached -$26000.0, down 101.35%, while the annual FY2025 figure was -$425000.0, 176.16% down from the prior year.
- Gains from Investment Securities reached -$444000.0 in Q4 2025 per RMTI's latest filing, down from $124000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $1.5 million in Q1 2024 to a low of -$547000.0 in Q4 2023.
- Average Gains from Investment Securities over 5 years is $140882.4, with a median of $128000.0 recorded in 2023.
- The largest YoY upside for Gains from Investment Securities was 3980.0% in 2023 against a maximum downside of 1380.0% in 2023.
- A 5-year view of Gains from Investment Securities shows it stood at $57000.0 in 2021, then surged by 970.18% to $610000.0 in 2022, then plummeted by 189.67% to -$547000.0 in 2023, then surged by 125.96% to $142000.0 in 2024, then plummeted by 412.68% to -$444000.0 in 2025.
- Per Business Quant, the three most recent readings for RMTI's Gains from Investment Securities are -$444000.0 (Q4 2025), $124000.0 (Q3 2025), and $148000.0 (Q2 2025).